[go: up one dir, main page]

WO2009013551A3 - Procédé de préparation d'un vaccin viral - Google Patents

Procédé de préparation d'un vaccin viral Download PDF

Info

Publication number
WO2009013551A3
WO2009013551A3 PCT/HR2008/000024 HR2008000024W WO2009013551A3 WO 2009013551 A3 WO2009013551 A3 WO 2009013551A3 HR 2008000024 W HR2008000024 W HR 2008000024W WO 2009013551 A3 WO2009013551 A3 WO 2009013551A3
Authority
WO
WIPO (PCT)
Prior art keywords
viral vaccine
preparing viral
preparing
vaccine
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/HR2008/000024
Other languages
English (en)
Other versions
WO2009013551A2 (fr
Inventor
Stanislav Cajavec
Neda Ergotic
Andrej Cizelj
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Veterina doo
Original Assignee
Veterina doo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veterina doo filed Critical Veterina doo
Publication of WO2009013551A2 publication Critical patent/WO2009013551A2/fr
Publication of WO2009013551A3 publication Critical patent/WO2009013551A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention porte sur un procédé de préparation d'un vaccin viral à plusieurs composants qui comporte la culture d'au moins deux espèces virales différentes dans un embryophore.
PCT/HR2008/000024 2007-07-25 2008-07-08 Procédé de préparation d'un vaccin viral Ceased WO2009013551A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0714489.2 2007-07-25
GB0714489A GB2451428A (en) 2007-07-25 2007-07-25 Process for preparing an in ovo combination viral vaccine

Publications (2)

Publication Number Publication Date
WO2009013551A2 WO2009013551A2 (fr) 2009-01-29
WO2009013551A3 true WO2009013551A3 (fr) 2009-03-19

Family

ID=38512836

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/HR2008/000024 Ceased WO2009013551A2 (fr) 2007-07-25 2008-07-08 Procédé de préparation d'un vaccin viral

Country Status (2)

Country Link
GB (1) GB2451428A (fr)
WO (1) WO2009013551A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102204933B (zh) * 2011-03-25 2012-10-10 天津济命生生物科技有限公司 一种抗肿瘤生物制品的制备方法
CN102205118B (zh) * 2011-03-25 2013-05-22 天津济命生生物科技有限公司 一种生物制品及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0565236A2 (fr) * 1992-03-09 1993-10-13 Abic Limited Vaccins inactivés de codage colorés pour la volaille
RU2058155C1 (ru) * 1993-02-09 1996-04-20 Всероссийский научно-исследовательский институт ветеринарной вирусологии и микробиологии Способ получения ассоциированной вирусвакцины против инфекционного ларинготрахеита и ньюкаслской болезни птиц
WO1998056413A1 (fr) * 1997-06-12 1998-12-17 Regents Of The University Of Minnesota Vaccin aviaire in ovo plurivalent
WO2000037101A1 (fr) * 1998-12-21 2000-06-29 Akzo Nobel N.V. Methode de production de vaccins inactives associes a une emulsion eau dans huile adjuvante
UA16452U (en) * 2006-01-30 2006-08-15 Instex And Clinical Veterinary Method for producing live lyophilized associated vaccine against infectious bursal disease (gamboro disease) and newcastle disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037650A (en) * 1988-03-08 1991-08-06 Akzo N.V. Live combination vaccine
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
ZA200104596B (en) * 2000-06-09 2001-12-06 Akzo Nobel Nv IBDV strain for in ovo administration.

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0565236A2 (fr) * 1992-03-09 1993-10-13 Abic Limited Vaccins inactivés de codage colorés pour la volaille
RU2058155C1 (ru) * 1993-02-09 1996-04-20 Всероссийский научно-исследовательский институт ветеринарной вирусологии и микробиологии Способ получения ассоциированной вирусвакцины против инфекционного ларинготрахеита и ньюкаслской болезни птиц
WO1998056413A1 (fr) * 1997-06-12 1998-12-17 Regents Of The University Of Minnesota Vaccin aviaire in ovo plurivalent
WO2000037101A1 (fr) * 1998-12-21 2000-06-29 Akzo Nobel N.V. Methode de production de vaccins inactives associes a une emulsion eau dans huile adjuvante
UA16452U (en) * 2006-01-30 2006-08-15 Instex And Clinical Veterinary Method for producing live lyophilized associated vaccine against infectious bursal disease (gamboro disease) and newcastle disease

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 199703, Derwent World Patents Index; AN 1997-032414, XP002501471 *
HIRST G K ET AL: "The experimental production of combination forms of virus. I. Occurrence of combination forms after simultaneous inoculation of the allantoic sac with two distinct strains of influenza virus.", THE JOURNAL OF EXPERIMENTAL MEDICINE JUL 1953, vol. 98, no. 1, July 1953 (1953-07-01), pages 41 - 52, XP002501469, ISSN: 0022-1007 *
HIRST G K ET AL: "The experimental production of combination forms of virus. II. A study of serial passage in the allantoic sac of agents that combine the antigens of two distinct influenza A strains.", THE JOURNAL OF EXPERIMENTAL MEDICINE JUL 1953, vol. 98, no. 1, July 1953 (1953-07-01), pages 53 - 70, XP002501470, ISSN: 0022-1007 *

Also Published As

Publication number Publication date
GB0714489D0 (en) 2007-09-05
WO2009013551A2 (fr) 2009-01-29
GB2451428A (en) 2009-02-04

Similar Documents

Publication Publication Date Title
WO2009121004A3 (fr) Molécules neutralisantes d'antigènes viraux
IL203869A (en) Method of Preparing a Containing a Virus or Antigen Antigen, Various Aspects Related to This Method, Uses of a Method and Vaccination of a Split Virus Prepared by This Method
WO2007126810A3 (fr) Virus de la grippe recombinants à haut titre pour vaccins
WO2010101663A3 (fr) Vaccins avec le virus vivant atténué de la grippe comprenant des éléments de réponse du type micro-arn
WO2009050390A3 (fr) Procede de production du virus de la grippe
PT2121011E (pt) Vacinas compreendendo um antigénio a partir de quatro estirpes do vírus da gripe
CY1120911T1 (el) Παραγομενες απο mdck κυτταρικες σειρες προσαρμοσμενες σε απαλλαγμενη απο ορο καλλιεργεια και καλλιεργεια εναιωρηματος και μεθοδος για παρασκευη ιου εμβολιου χρησιμοποιωντας τα κυτταρα
BRPI0716536A2 (pt) produÇço de vacinas de vÍrus influenza, sem a utilizaÇço de ovos
WO2011022656A3 (fr) Vaccin recombinant contre le paramyxovirus aviaire, sa méthode de fabrication et d'utilisation
WO2010132604A3 (fr) Molécules neutralisantes dirigées contre les virus de la grippe
ZA200908152B (en) Duck embryonic derived stem cell lines for the production of viral vaccines
WO2007052163A3 (fr) Vaccins viraux derives de cellules, presentant de faibles niveaux d'adn cellulaire residuel
BR112014001049A2 (pt) método para a produção de um antígeno viral derivado de vírus envelopado, e, uso de um método para a fabricação de uma preparação de vacina contendo o antígeno viral
WO2008147496A3 (fr) Vaccins de la grippe vivants déficients en neuraminidase
EP1977015A4 (fr) Anticorps monoclonaux qui se lient à l'hémagglutinine de la sous-classe h5 du virus de la grippe aviaire et leurs utilisations
WO2007048089A3 (fr) Systeme a plasmides multiples de production de virus de la grippe
WO2008076371A3 (fr) Procédé destiné à répliquer le virus de la grippe en culture
WO2008049974A8 (fr) Vaccin peptidique contre le virus de la grippe
WO2009115917A3 (fr) Améliorations dans la préparation des antigènes pour le vaccin contre le virus de la grippe
WO2009080806A3 (fr) Virus influenza modifié
ZA200905952B (en) Lyophilized preparation comprising influenza vaccine,and method for preparation thereof
ZA201004531B (en) Method for producing vaccinal viral strain of a virus of the reoviridae family
WO2008124176A3 (fr) Formes solubles et ancrées sur membrane de protéines de sous-unité du virus lassa
WO2010040572A3 (fr) Anticorps
WO2010093537A3 (fr) Hémagglutinine du virus de la grippe et variants de la neuraminidase

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08776238

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08776238

Country of ref document: EP

Kind code of ref document: A2